comparemela.com

Latest Breaking News On - Anual de dermat - Page 1 : comparemela.com

Mary Kay continues its decades-long commitment to skin care innovation with new research on retinol tolerance

Mary Kay continues its decades-long commitment to skin care innovation with new research on retinol tolerance 14 hours ago 11 hours ago Mary Kay was proud to share research on a gradual retinization process that significantly improves tolerance to higher concentrated pure retinol, while still delivering retinol’s key skin benefits. ANTARA/Business Wire Global Cosmetics Company Presents Latest Skin Science Research at the 2021 Reunión Anual de Dermatólogos Latinoamericanos Dallas (Antara/Business Wire)- As one of the world’s leading innovators in skin science research for nearly six decades, Mary Kay Inc. continues its longstanding commitment to the advancement of cutting-edge skin care at the 2021 Reunión Anual de Dermatólogos Latinoamericanos (RADLA), a scientific Latin American conference. The virtual event held April 15-18 provided an opportunity for dermatology experts worldwide to exchange information on technological advances and new scientific achievements.

Mary Kay Continues Its Decades-Long Commitment to Skin Care Innovation With New Research on Retinol Tolerance

Mary Kay Continues Its Decades-Long Commitment to Skin Care Innovation With New Research on Retinol Tolerance Global Cosmetics Company Presents Latest Skin Science Research at the 2021 Reunión Anual de Dermatólogos Latinoamericanos DALLAS (BUSINESS WIRE) As one of the world’s leading innovators in skin science research for nearly six decades, Mary Kay Inc. continues its longstanding commitment to the advancement of cutting-edge skin care at the 2021 Reunión Anual de Dermatólogos Latinoamericanos (RADLA), a scientific Latin American conference. The virtual event held April 15-18 provided an opportunity for dermatology experts worldwide to exchange information on technological advances and new scientific achievements.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.